Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma.
Journal: Blood cancer journal
Published: January 27, 2026
Radiotherapy in the treatment of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Journal: International journal of dermatology
Published: April 15, 2024
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial.
Journal: The Lancet. Haematology
Published: February 13, 2024
Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study.
Journal: JCO global oncology
Published: August 08, 2022
Incidence and time course of neutropenia in patients treated with rituximab-based therapy for non-malignant immune-mediated hematologic diseases.
Journal: American journal of hematology
Published: January 03, 2020
Adherence to infectious disease screening and immunization guidelines when treating non-malignant immune-mediated hematologic disorders.
Journal: American journal of hematology
Published: December 08, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026